Gainers
- Biodexa Pharmaceuticals BDRX stock moved upwards by 116.2% to $8.8 during Monday's pre-market session. The market value of their outstanding shares is at $5.8 million.
- Ocean Biomedical OCEA shares moved upwards by 70.57% to $0.23. The company's market cap stands at $7.9 million.
- Solid Biosciences SLDB shares rose 25.0% to $3.6. The market value of their outstanding shares is at $143.8 million.
- IMAC Hldgs BACK stock moved upwards by 22.89% to $0.74. The market value of their outstanding shares is at $1.5 million.
- Foghorn Therapeutics FHTX stock rose 17.05% to $5.56. The company's market cap stands at $309.2 million.
- Axsome Therapeutics AXSM shares increased by 15.83% to $122.51. The market value of their outstanding shares is at $5.9 billion.
Losers
- Pliant Therapeutics PLRX shares decreased by 61.5% to $3.0 during Monday's pre-market session. The company's market cap stands at $182.5 million.
- CytoMed Therapeutics GDTC stock fell 14.6% to $2.4. The company's market cap stands at $27.6 million.
- ImmuCell ICCC stock decreased by 11.94% to $4.5. The company's market cap stands at $40.1 million.
- Microbot Medical MBOT shares declined by 10.99% to $2.27. The company's market cap stands at $63.6 million.
- Cyclo Therapeutics CYTH stock fell 10.93% to $1.06. The market value of their outstanding shares is at $34.7 million.
- Omega Therapeutics OMGA stock declined by 10.18% to $0.1. The company's market cap stands at $5.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BACKIMAC Holdings Inc
$0.6679-7.58%
BDRXBiodexa Pharmaceuticals PLC
$4.32-0.02%
CYTHCyclo Therapeutics Inc
$0.9004-3.20%
FHTXFoghorn Therapeutics Inc
$6.000.64%
GDTCCytoMed Therapeutics Ltd
$2.51-3.83%
ICCCImmuCell Corp
$4.90-2.39%
MBOTMicrobot Medical Inc
$1.82-4.95%
OCEAOcean Biomedical Inc
$0.1246-5.46%
OMGAOmega Therapeutics Inc
$0.1984-6.02%
PLRXPliant Therapeutics Inc
$2.990.34%
SLDBSolid Biosciences Inc
$6.0113.5%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in